Embracing Diversity & Inclusion
-
2 Key Ways To Improve Patient Recruitment Of Minorities In Clinical Trials – A Participant’s Perspective
6/1/2021
John A. Reaves was compelled to participate in clinical trials for a COVID-19 vaccine. In this article, he discusses his experience and provides two recommendations, including potential strategies for accomplishing them, for how the industry can improve recruitment of minorities for clinical trials.
-
Diverse Patient Populations In Clinical Research: 3 Steps For Success
5/5/2021
While the clinical trials industry has made incredible strides raising awareness among the broader general population, as we’ve witnessed firsthand amid the ongoing COVID-19 pandemic, there remains a persistent lack of representation in clinical research among diverse communities. How do we address this?
-
Turning Point In U.S. History: Our Chance To Do Better With Clinical Trials
2/16/2021
We are at the beginning of important conversations. Conversations that need to happen so we can definitively address the health disparities that continue to impact outcomes among ethnic and racial groups in the United States.
-
Addressing Disparities And The Democratization Of Clinical Trials
1/14/2021
Advancements of the protocols, tools, and technologies that were highly leveraged during the COVID-19 pandemic are the key to breaking down the barriers that perpetuate clinical trial disparities.
-
Let’s Tackle The Hidden Real-World Reasons For Poor Clinical Trial Diversity
12/17/2020
To achieve better outcomes and health equity for historically underserved populations, we must address the not widely acknowledged, hidden, real-world reasons for such poor diversity in clinical trials. Here, we will pull back the covers on the issues we must tackle to improve diversity in trials.
-
How EMD Serono Is Bringing Diverse Patient Voices Together
11/3/2020
The pandemic has created an opportunity to address some of the causes underlying clinical care inequities. And while combatting these issues will take time, much can be done by first addressing the gap for minorities in clinical trials. This is a topic I am passionate about both personally and professionally as a female Hispanic chief medical officer.
-
Increasing Diversity In Clinical Trials: The Critical Role Of Community Partnerships & Collaborations
10/6/2020
Meaningful long-term engagement, collaborations, and partnerships — rather than those based on specific trial or project needs — deepen community relationships, build trust, gain an understanding of community priorities, and make research programs more responsive to the needs, values, and perspectives of the affected populations.
-
9 Factors For Driving Inclusivity & Patient Centricity In A Transformed Clinical Trials Landscape
9/15/2020
Patient-centricity, quality, and inclusion are not natural consequences of the shift to virtual clinical trials. To be intentional with the design, we must start with articulating and understanding the full contexts of patients’ lives, medical and beyond.
-
How FDA Is Helping Advance Clinical Trial Diversity
9/1/2020
An update from the FDA Office of Minority Health and Health Equity on its efforts to address health disparities and health equity — and ultimately strengthen the agency’s ability to respond to minority health concerns.
-
How Can We Begin To Solve Unconscious Systemic Bias In Clinical Trials?
8/4/2020
Halting disparities in clinical trials during the time of COVID-19 will take eradicating unconscious bias, building trust in diverse communities, dispelling long-held myths, constructing relationships, and educating patients, family members, and physicians.